As shown in Table 2, DRAM2 overexpression was associated with tumor node metastases (TNM) stages (p = 0.025) and lymph node metastasis (p = 0.035), but did not correlate with age, biological sex, histology, or tumor differentiation (p > 0.05). This evidence concerns the gene DRAM2 and neoplasm.